This is a Notice of Intent, not a request for quotes. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis to procure a qty. of 1 Biosensor Ni-NTA (NTA) -Twenty trays and qty. of 2 Biosensor Anti-hIgG Capture (AHC)- Twenty tray for both quantitation and kinetic applications of HIS-tagged molecules from ForteBio, a Division of Pall Life Sciences, 1360 Willow Road, Suite 201, Menlo Park, CA 94025.

The goal is to translate basic research into concrete vaccine products that can be rapidly deployed to protect public health. The Forte Bio Octet machine that is currently in use by NIAID is a critical aspect in meeting NIAID goals, allowing researchers to assess antibodies and immunogens involved in active immunization studies and passive protection studies in a high-throughput manner with high reproducibility and reliability. Consumables for the Fortebio Octet currently in use by NIAID are only manufactured and sold by ForteBio. To change systems / consumables at this time would cause variables in data that would adversely affect years of research.

Place of delivery is Bethesda, MD 20892.

The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply will satisfy agency requirements. THIS IS NOT A REQUEST FOR Quotes. All responsible sources that could provide this requirement may submit a capability statement that will be considered by email (subject line to reference: NIAID-NOI-17-1864215 to [email protected]) by 5:00 pm eastern standard time Tuesday, September 5, 2017. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

 

Bid Protests Not Available